Combined treatment with ezetimibe/simvastatin plus niacin was associated with a similar safety profile to treatment with either agent alone

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1632, 2008-01, pp. : 24-24

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

US FDA reviewing safety of ezetimibe/simvastatin

By  

Reactions Weekly, Vol. 1, Iss. 1217, 2008-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

US FDA reviewing safety of ezetimibe/simvastatin

By  

Inpharma, Vol. 1, Iss. 1653, 2008-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite

Pretreatment with lidocaine plus remifentanil is more effective than either agent alone for preventing pain associated with propofol injection

By  

Inpharma, Vol. 1, Iss. 1595, 2007-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

Ezetimibe–Simvastatin, a pharmacodynamic interaction?

By Lozano Roberto   Marin Reyes   Santacruz M-Jesus   Freire Isabel  

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 3, 2013-02 ,pp. : 359-360

Informa Healthcare

Access to resources Recommend Favorite

Efficacy, Safety and Tolerability of Combined Low-Dose Simvastatin-Fenofibrate Treatment in Primary Mixed Hyperlipidaemia

By C. Stefanutti  

Clinical Drug Investigation, Vol. 24, Iss. 8, 2004-01 ,pp. : 465-477

Adis International

Access to resources Recommend Favorite